Home › Phase III data show investigational compound empagliflozin...
 

Keywords :   


Phase III data show investigational compound empagliflozin...

2013-06-22 19:08:23| Biotech - Topix.net

In the pooled analysis, presented at the American Diabetes Association 73rd Scientific SessionsA , people with T2D treated with empagliflozin versus placebo achieved significant reductions in HbA1c, fasting plasma glucose , weight and blood pressure after 24 weeks.1 In the same analysis, people treated with empagliflozin vs. placebo experienced an ... (more)

Tags: show data iii phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »